Canada’s generic pharmaceutical industry continues to play a critical role in maintaining affordable access to medicines, supporting pharmacy supply chains and strengthening domestic pharmaceutical capabilities. In 2026, the competitive landscape is being shaped not only by conventional generics, but also by complex generics, biosimilars, sterile injectables, specialty medicines, product launches and supply-resilience initiatives. The companies...
Takeaways: Signia’s Multi‑adaptive Xperience (MaX) launch in Canada brings an AI‑driven, four‑DNN platform (speech, noise, environment, own‑voice) that the company says is the first of its kind in hearing aids, positioning it as a premium option for adults struggling in social settings. The first device, Pure C&G MaX, ships with OneConnect (Bluetooth Classic + LE...
